Vestmark Advisory Solutions Inc. Trims Holdings in Align Technology, Inc. $ALGN

Vestmark Advisory Solutions Inc. trimmed its position in shares of Align Technology, Inc. (NASDAQ:ALGN) by 28.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,126 shares of the medical equipment provider’s stock after selling 449 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in Align Technology were worth $213,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of ALGN. Redmond Asset Management LLC boosted its position in shares of Align Technology by 2.0% during the 1st quarter. Redmond Asset Management LLC now owns 2,769 shares of the medical equipment provider’s stock valued at $440,000 after acquiring an additional 54 shares during the last quarter. Horizon Investments LLC raised its stake in Align Technology by 6.2% during the 1st quarter. Horizon Investments LLC now owns 1,018 shares of the medical equipment provider’s stock worth $162,000 after acquiring an additional 59 shares in the last quarter. Atria Investments Inc raised its position in Align Technology by 4.9% in the 2nd quarter. Atria Investments Inc now owns 1,575 shares of the medical equipment provider’s stock valued at $298,000 after purchasing an additional 74 shares during the last quarter. IFP Advisors Inc grew its position in Align Technology by 5.7% in the 2nd quarter. IFP Advisors Inc now owns 1,427 shares of the medical equipment provider’s stock valued at $270,000 after buying an additional 77 shares during the last quarter. Finally, Covestor Ltd raised its position in Align Technology by 18.8% in the first quarter. Covestor Ltd now owns 493 shares of the medical equipment provider’s stock worth $78,000 after acquiring an additional 78 shares in the last quarter. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Align Technology Price Performance

NASDAQ:ALGN opened at $142.23 on Thursday. Align Technology, Inc. has a fifty-two week low of $122.00 and a fifty-two week high of $246.19. The stock has a market cap of $10.21 billion, a PE ratio of 27.43, a price-to-earnings-growth ratio of 1.49 and a beta of 1.84. The stock’s 50-day moving average is $132.86 and its two-hundred day moving average is $159.72.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings results on Wednesday, October 29th. The medical equipment provider reported $2.61 earnings per share for the quarter, topping analysts’ consensus estimates of $2.38 by $0.23. The company had revenue of $995.69 million during the quarter, compared to the consensus estimate of $980.75 million. Align Technology had a return on equity of 14.06% and a net margin of 9.50%.The business’s quarterly revenue was up 1.8% on a year-over-year basis. During the same period last year, the business earned $2.35 EPS. Align Technology has set its Q4 2025 guidance at EPS. On average, equities research analysts anticipate that Align Technology, Inc. will post 7.98 earnings per share for the current year.

Align Technology announced that its board has initiated a stock buyback program on Tuesday, August 5th that permits the company to buyback $200.00 million in shares. This buyback authorization permits the medical equipment provider to repurchase up to 2% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s management believes its shares are undervalued.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on ALGN shares. Wall Street Zen raised Align Technology from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Evercore ISI lifted their price objective on Align Technology from $160.00 to $170.00 and gave the stock an “outperform” rating in a report on Thursday, October 30th. UBS Group decreased their price target on Align Technology from $160.00 to $155.00 and set a “neutral” rating for the company in a research note on Thursday, October 16th. HSBC raised their price target on shares of Align Technology from $140.00 to $150.00 in a research report on Friday, October 31st. Finally, Mizuho lowered their price objective on Align Technology from $210.00 to $170.00 and set an “outperform” rating for the company in a research note on Monday, October 13th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $175.45.

About Align Technology

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.